THE POTENTIAL LONG-TERM COMPARATIVE EFFECTIVENESS OF LAROTRECTINIB VS. LENVATINIB OR SORAFENIB FOR TREATMENT OF NTRK FUSION-POSITIVE METASTATIC THYROID CANCER

被引：0
|
作者：
Carlson, J. [1 ]
Suh, K. [2 ]
Xia, F. [3 ]
Williamson, T. [3 ]
Sullivan, S. [4 ]
机构：
[1] Univ Washington, Seattle, WA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Bayer US LLC, Whippany, NJ USA
[4] Univ Washington, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN11
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [21] Long-term trastuzumab treatment in HER2 positive metastatic breast cancer
    Calamac, M.
    Minic, I.
    Tomasevic, Z.
    Oblakovic-Babic, J.
    Serovic, K.
    Djurmez, O.
    Dimitrijevic, M.
    Bozovic-Spasojevic, I.
    BREAST, 2021, 56 : S82 - S83
  • [22] Long-term functional outcome after treatment of prostate cancer: Radical prostatectomy vs. brachytherapy
    Trojan, L.
    Harrer, K.
    Bolenz, C.
    Heinrich, E.
    Schaefer, J.
    Welzl, W. G.
    Wenz, F.
    Aiken, P.
    Michel, M. S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 168 - 168
  • [23] Long-term, treatment-free survival in select patients with distant metastatic papillary thyroid cancer
    Kwong, Norra
    Marqusee, Ellen
    Gordon, Michael S.
    Larsen, P. Reed
    Garber, Jeffrey R.
    Kim, Matthew I.
    Alexander, Erik K.
    ENDOCRINE CONNECTIONS, 2014, 3 (04):
  • [24] Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Meniere's disease: A long-term comparative study
    Schmerber, Sebastien
    Dumas, Georges
    Morel, Nils
    Chahine, Karim
    Karkas, Alexandre
    AURIS NASUS LARYNX, 2009, 36 (04) : 400 - 405
  • [25] Comparative Effectiveness of Homoeopathic vs. Conventional Therapy in Usual Care of Atopic Eczema in Children: Long-Term Medical and Economic Outcomes
    Roll, Stephanie
    Reinhold, Thomas
    Pach, Daniel
    Brinkhaus, Benno
    Icke, Katja
    Staab, Doris
    Jaeckel, Tanja
    Wegscheider, Karl
    Willich, Stefan N.
    Witt, Claudia M.
    PLOS ONE, 2013, 8 (01):
  • [26] Modelling the potential long-term survival benefit of evinacumab treatment vs. standard of care in patients with homozygous familial hypercholesterolaemia
    Gu, Jing
    Kuznik, Andreas
    Quon, Peter
    Chauhan, Ankita
    Sravya, Tupili S.
    Raal, Frederick J.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (17) : 1874 - 1880
  • [27] Effects of Cancer Immunotherapy Regimens on Primary vs. Secondary Immune Responses and the Potential Impact on Long-Term Antitumor Responses
    Alderson, Kory L.
    Murphy, William J.
    CROSSROADS BETWEEN INNATE AND ADAPTIVE IMMUNITY II, 2009, 633 : 81 - 89
  • [28] Short-term ablative effectiveness of dosimetry-guided vs. empiric methods in the treatment of differentiated thyroid cancer with 131I
    Perotti, G.
    De Lauro, F.
    Casi, M.
    Agostini, M.
    Severi, S.
    Sarti, G.
    Dottorini, M. E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S159 - S159
  • [29] Entrectinib as first-line vs. second-line therapy in ROS1 fusion-positive non-small cell lung cancer: a cost-effectiveness analysis
    Huo, Gengwei
    Song, Ying
    Chen, Xiongwen
    Chen, Peng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04) : 839 - 848
  • [30] Comparative Long-term Morbidity of Intensity Modulated vs. Conformal Radiation Therapy (RT) for Prostate Cancer: A SEER-Medicare Analysis
    Sheets, N.
    Goldin, G. H.
    Meyer, A. M.
    Darter, J. D.
    Wu, Y.
    Holmes, J. A.
    Reeve, B. B.
    Godley, P. A.
    Carpenter, W. R.
    Chen, R. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S43 - S43
12345